CHF139.50
1.45% today
SIX Swiss Exchange, Sep 23, 05:31 pm CET
ISIN
CH0187624256
Symbol
VBSN

Ivf Hartmann Holding Stock price

CHF139.50
-2.50 1.76% 1M
-9.61 6.45% 6M
-7.65 5.20% YTD
+2.16 1.57% 1Y
+43.38 45.14% 3Y
-20.56 12.85% 5Y
-1.73 1.23% 10Y
+111.07 390.60% 20Y
SIX Swiss Exchange, Closing price Tue, Sep 23 2025
+2.00 1.45%
ISIN
CH0187624256
Symbol
VBSN

Key metrics

Basic
Market capitalization
CHF337.2m
Enterprise Value
CHF243.7m
Net debt
positive
Cash
CHF94.2m
Shares outstanding
2.4m
Valuation (TTM | estimate)
P/E
17.4 | -
P/S
2.1 | -
EV/Sales
1.5 | -
EV/FCF
17.3
P/B
2.3
Dividends
DPS
CHF6.20
Yield 1Y | 5Y
2.3% | 2.2%
Growth 1Y | 5Y
1.9% | 6.3%
Payout 1Y | 3Y
95.1% | 62.8%
Increased
3 Years
Financials (TTM | estimate)
Revenue
CHF159.5m | -
EBITDA
CHF27.3m | -
EBIT
CHF22.1m | -
Net Income
CHF19.0m | -
Free Cash Flow
CHF14.1m
Growth (TTM | estimate)
Revenue
4.3% | -
EBITDA
7.9% | -
EBIT
13.3% | -
Net Income
7.8% | -
Free Cash Flow
-52.1%
Margin (TTM | estimate)
Gross
55.7%
EBITDA
17.1% | -
EBIT
13.9%
Net
11.9% | -
Free Cash Flow
8.8%
Financial Health
Equity Ratio
80.4%
Return on Equity
13.4%
ROCE
14.8%
ROIC
28.4%
Debt/Equity
0.0
More
EPS
CHF7.9
FCF per Share
CHF5.9
Short interest
-
Employees
270
Rev per Employee
CHF590.0k
Show more

Is Ivf Hartmann Holding a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,013 stocks worldwide.

Financial data from Ivf Hartmann Holding

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
159 159
4% 4%
100%
- Direct Costs 71 71
3% 3%
44%
89 89
5% 5%
56%
- Selling and Administrative Expenses 31 31
1% 1%
19%
- Research and Development Expense - -
-
-
27 27
8% 8%
17%
- Depreciation and Amortization 5.19 5.19
10% 10%
3%
EBIT (Operating Income) EBIT 22 22
13% 13%
14%
Net Profit 19 19
8% 8%
12%

In millions CHF.

Don't miss a Thing! We will send you all news about Ivf Hartmann Holding directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

IVF HARTMANN Holding AG engages in the production and distribution of medical consumer products. It operates through the following segments: Wound Management, Incontinence Management, Risk Prevention, Disinfection, Personal Healthcare, and Facility Products. The Wound Management segment provides traditional wound treatment; negative pressure wound therapy; as well as compression and support therapy. The Incontinence Management segment offers securing systems; medicinal skin care; including patient and personal hygiene. The Risk Prevention segment provides disposable surgical instruments, surgical clothing, as well as surgical and examination gloves. The Disinfection segment sells hand disinfection, hand protection, and skin disinfection. The Personal Healthcare segment markets plaster and wound dressings; thermometers; and sphygmomanometers. The Facility Products segment supplies hygienic paper, microfiber wipes, and foils products. The company was founded on April 13, 1883 and is headquartered in Neuhausen, Switzerland.

Head office Switzerland
CEO Claus Martini
Employees 270
Founded 1883
Website www.ivf.hartmann.info

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today